Request an Appointment
Whether you need a second opinion or advanced treatment, our pediatric endocrinologists can help. Complete the form and we will contact you within one business day.
All fields required
Whether you need a second opinion or advanced treatment, our pediatric endocrinologists can help. Complete the form and we will contact you within one business day.
All fields required
Connecticut Children’s Center for Rare Bone Disorders has a team dedicated to the management and care of many genetic and metabolic bone disorders, including:
Specialists focused on treating rare pediatric bone disorders are in your neighborhood. Choose one of three convenient locations for pediatric care:
Connecticut Children’s Center for Rare Bone Disorders is led by Emily Germain-Lee, MD, a world-renowned pediatric endocrinologist specializing in rare bone disorders. In partnership with The Jackson Laboratory and UConn Health, she conducts clinical research focused on:
In December, Dr. Germain-Lee and distinguished researcher Se-Jin Lee, MD, PhD sent genetically-engineered “Mighty Mice” to the International Space Station to explore the potential that myostatin-inhibitors hold for treating muscle and bone loss. This could benefit everyone from astronauts—helping prevent skeletal muscle and bone loss during spaceflight and enhance recovery following their return to Earth—to people who are suffering from muscle atrophy and bone degeneration-related conditions.
Learn more about Dr. Germain-Lee and why she chose to pursue a career specializing in rare bone disorders.
Learn MoreAfter 15 years and multiple misdiagnoses, Simon’s mom finally found the right doctor and a medical “home” for his rare bone disorder.
Read Simon's StoryDillon and Ellie’s parents travel to Connecticut from Virginia to see Dr. Germain-Lee, who specializes in pseudohypoparathyroidism type 1A.
Watch Dillon & Ellie's StoryWe sat down with Dr. Germain-Lee to discuss her advances in the treatment and research of rare bone and endocrine disorders.
Read the Q&AOur center for Osteogenesis Imperfecta (OI), or brittle bone disease, is recognized by the Osteogenesis Imperfecta Foundation and is a premier site in New England and the Mid-Atlantic for evaluating and managing patients with OI. The center is led by Dr. Germain-Lee and pediatric endocrinologist Nancy Dunbar, MD, MPH.
Our Center for Rare Bone Disorders is home to the Albright Center, the first and only center in the world dedicated to AHO. Because she follows the largest population of AHO patients worldwide, Dr. Germain-Lee can often identify and address underlying issues common to AHO patients before they progress, improving patients’ long-term health and quality of life.